PLXNC1 and neoplasm: This study used an objective method to analyze published gene expression data from pre-treated tumors and drug-resistant tumors, and identified possible targets and markers for resistant tumors, which centered on the PLXNC1 gene, which promotes a pro-inflammatory tumor microenvironment.